Ranking · Summer 2018 · Healthcare · Therapeutics

Rejuvenation Technologies Inc.

mRNA therapeutics to extend healthspan entering clinical trials

6.2%

odds of being acquired in the next two years

0.9× the average (6.8%)

#2518 of 4,339 active YC companies · top 59%

Team of 2 · San Francisco, CA, USA

Raises the odds

↑ based in United States of America

↑ rewrote its description in the last six months

↑ based in America / Canada

↑ changed its name (pivot)

Lowers the odds

↓ team of 1–2

↓ industry: Healthcare

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Rejuvenation Technologies Inc.'s website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

rejuvenationtech.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub